Constellation to acquire Calpine for $16.4bn
Constellation has announced its acquisition of Calpine in a cash and stock transaction valued at $16.4bn, including 50 million Constellation shares, $4.5bn in cash, and the assumption of $12.7bn in net debt. The deal brings the total net purchase price to $26.6bn after factoring in expected cash generated by Calpine and tax attributes. The transaction, expected to close by January 2026, is subject to regulatory approvals and customary conditions. Constellation plans to fund the cash…